ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

RITUXIMABUM

Active substance (INN) · ATC L01FA01 · 12 products authorised in Romania
◀ Back
1

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

CodeProtocolStatusRoleSublistGP
L014C RITUXIMABUM (original si biosimilar) In force medicine of the protocol C2-P3 NO
L01FA01 RITUXIMABUM In force medicine of the protocol C1-G27 NO
L01XC-L04AJ VASCULITE ANCA POZITIVE - DCI RITUXIMABUM**1 (original și biosimilar) și DCI AVACOPAN**1Ω In force medicine of the protocol C1-G17 NO
L01XC02 RITUXIMABUM In force medicine of the protocol C1-G17 NO
L043M POLIARTRITA REUMATOIDĂ - AGENŢI BIOLOGICI: INFLIXIMABUM**1 (ORIGINAL ŞI BIOSIMILAR), ETANERCEPTUM**1 (ORIGINAL ŞI BIOSIMILAR), ADALIMUMABUM**1 (ORIGINAL ŞI BIOSIMILAR), G… In force medicine of the protocol C1-G31B NO
BD01D HEMOFILIA A si B si BOALA VON WILLEBRAND In force mentioned in the text C2-P6.1 NO
L01EL02 ACALABRUTINIBUM In force mentioned in the text C2-P3 NO
L01EL03 ZANUBRUTINIBUM In force mentioned in the text C2-P3 NO
L01XC15 OBINUTUZUMAB In force mentioned in the text C2-P3 NO
L01XC37 POLATUZUMAB VEDOTIN In force mentioned in the text C2-P3 NO
L01XE27 IBRUTINIBUM In force mentioned in the text C2-P3 NO
L01XX52 VENETOCLAX In force mentioned in the text C2-P3 NO
L048C FLUDARABINUM In force mentioned in the text C2-P3 YES
L04AA26-51 LUPUS ERITEMATOS SISTEMIC - AGENŢI BIOLOGICI: BELIMUMABUM**1, ANIFROLUMABUM**1 In force mentioned in the text C1-G17 NO
LB01B HEPATITĂ CRONICĂ ŞI CIROZĂ HEPATICĂ CU VIRUS VHB In force mentioned in the text C1-G4,G7 YES
2

History: entries into and exits from protocols

MonthTypeCodeProtocolLevel
July 2026Medicine added LB01BHEPATITĂ CRONICĂ ŞI CIROZĂ HEPATICĂ CU VIRUS VHB mentioned in the text
April 2026Medicine added L01EL03ZANUBRUTINIBUM mentioned in the text
March 2026Medicine added L01EL02ACALABRUTINIBUM mentioned in the text
3

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand nameFormStrengthHolderATCRx
ITUXREDI 100mgCONC. PT. SOL. PERF.100mgREDDY HOLDING GMBH - GERMANIAL01FA01PR
ITUXREDI 500mgCONC. PT. SOL. PERF.500mgREDDY HOLDING GMBH - GERMANIAL01FA01PR
MABTHERA 100 mgCONC. PT. SOL. PERF.10mg/mlROCHE REGISTRATION GMBH - GERMANIAL01FA01PR
MABTHERA 1400 mgSOL. INJ.120mg/mlROCHE REGISTRATION GMBH - GERMANIAL01FA01PR
MABTHERA 1600 mgSOL. INJ.120mg/mlROCHE REGISTRATION GMBH - GERMANIAL01FA01PR
MABTHERA 500 mgCONC. PT. SOL. PERF.10mg/mlROCHE REGISTRATION GMBH - GERMANIAL01FA01PR
RIXATHON 100 mgCONC. PT. SOL. PERF.100mgSANDOZ GMBH - AUSTRIAL01FA01PR
RIXATHON 500 mgCONC. PT. SOL. PERF.500mgSANDOZ GMBH - AUSTRIAL01FA01PR
RUXIENCE 100mgCONC. PT. SOL. PERF.100mgPFIZER EUROPE MA EEIG - BELGIAL01FA01PR
RUXIENCE 500mgCONC. PT. SOL. PERF.500mgPFIZER EUROPE MA EEIG - BELGIAL01FA01PR
TRUXIMA 100 mgCONC. PT. SOL. PERF.100mgCELLTRION HEALTHCARE HUNGARY KFT. - UNGARIAL01FA01PR
TRUXIMA 500 mgCONC. PT. SOL. PERF.500mgCELLTRION HEALTHCARE HUNGARY KFT. - UNGARIAL01FA01PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.